Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 134

    1.

    Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

    Emamaullee JA, Davis J, Merani S, Toso C, Elliott JF, Thiesen A, Shapiro AM.

    Diabetes. 2009 Jun;58(6):1302-11. Epub 2009 Mar 16.PMID: 19289457 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice.

    Khil LY, Jun HS, Kwon H, Yoo JK, Kim S, Notkins AL, Yoon JW.

    Diabetologia. 2007 Oct;50(10):2147-55. Epub 2007 Aug 4.PMID: 17676307 [PubMed - indexed for MEDLINE]Related articles

    3.

    A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.

    Balasa B, La Cava A, Van Gunst K, Mocnik L, Balakrishna D, Nguyen N, Tucker L, Sarvetnick N.

    J Immunol. 2000 Dec 15;165(12):7330-7.PMID: 11120869 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.

    Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV.

    Cell Immunol. 2005 May;235(1):1-11. Epub 2005 Aug 24.PMID: 16122720 [PubMed - indexed for MEDLINE]Related articles

    5.

    A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice.

    Tisch R, Wang B, Atkinson MA, Serreze DV, Friedline R.

    J Immunol. 2001 Jun 1;166(11):6925-36.PMID: 11359854 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.
    7.

    Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

    Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

    Transplantation. 2004 Apr 15;77(7):990-7.PMID: 15087759 [PubMed - indexed for MEDLINE]Related articles

    8.

    Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice.

    Han J, Zhong J, Wei W, Wang Y, Huang Y, Yang P, Purohit S, Dong Z, Wang MH, She JX, Gong F, Stern DM, Wang CY.

    Diabetes. 2008 Aug;57(8):2118-27. Epub 2008 May 13.PMID: 18477810 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.

    Jun HS, Chung YH, Han J, Kim A, Yoo SS, Sherwin RS, Yoon JW.

    Diabetologia. 2002 May;45(5):668-76. Epub 2002 Apr 4.PMID: 12107747 [PubMed - indexed for MEDLINE]Related articles

    10.

    Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.

    Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M.

    J Immunol. 1996 Oct 15;157(8):3737-43.PMID: 8871677 [PubMed - indexed for MEDLINE]Related articles

    11.

    Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.

    Drage M, Zaccone P, Phillips JM, Nicoletti F, Dawson J, Andrew Bradley J, Cooke A.

    Transplantation. 2002 Sep 15;74(5):611-9.PMID: 12352875 [PubMed - indexed for MEDLINE]Related articles

    12.

    Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585).

    Han G, Li Y, Wang J, Wang R, Chen G, Song L, Xu R, Yu M, Wu X, Qian J, Shen B.

    J Immunol. 2005 Apr 15;174(8):4516-24.PMID: 15814672 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens.

    Cetkovic-Cvrlje M, Gerling IC, Muir A, Atkinson MA, Elliott JF, Leiter EH.

    Diabetes. 1997 Dec;46(12):1975-82. Erratum in: Diabetes 1998 Feb;47(2):303. PMID: 9392483 [PubMed - indexed for MEDLINE]Related articles

    14.

    Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.

    Tian J, Atkinson MA, Clare-Salzler M, Herschenfeld A, Forsthuber T, Lehmann PV, Kaufman DL.

    J Exp Med. 1996 Apr 1;183(4):1561-7.PMID: 8666914 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.

    Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R.

    Diabetes. 2007 May;56(5):1395-402. Epub 2007 Feb 22.PMID: 17317763 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.

    Suarez-Pinzon W, Rajotte RV, Mosmann TR, Rabinovitch A.

    Diabetes. 1996 Oct;45(10):1350-7.PMID: 8826970 [PubMed - indexed for MEDLINE]Related articles

    18.

    Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells.

    Martin-Orozco N, Chung Y, Chang SH, Wang YH, Dong C.

    Eur J Immunol. 2009 Jan;39(1):216-24.PMID: 19130584 [PubMed - indexed for MEDLINE]Related articles

    19.

    Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.

    Quinn A, McInerney B, Reich EP, Kim O, Jensen KP, Sercarz EE.

    J Immunol. 2001 Mar 1;166(5):2982-91.PMID: 11207247 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Genetic and therapeutic control of diabetogenic CD8+ T cells.

    Santamaria P.

    Novartis Found Symp. 2008;292:130-6; discussion 136-45, 202-3.PMID: 19209463 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data